A summary of customers, suppliers, and logistics partners for the latest 3 U.S. imports by Aurolife Pharma L L C 301 6 Wheeli are presented below. In total, 3 import manifest records have been entered for Aurolife Pharma L L C 301 6 Wheeli since January 2018. Click the shipment ID for full Bill of Lading information.
AUROBINDO PHARMA LTD., | 91-4066725112 | 3 |
AGILITY LOGISTICS CORP | 1-7187129444 | 3 |
Shipment ID | Supplier Notified Party [Logistics] | Receiver / Consignee |
---|---|---|
2020061816436 | AUROBINDO PHARMA LTD.,
CORP OFFICE : THE WATER MARK BUILDI Departure Port Nhava Sheva,India AGILITY LOGISTICS CORP HEIDI MONAHAN-GREY, IMPORT SUPERVIS |
AUROLIFE PHARMA LLC, 301-6 WHEELI DAYTON, NJ08810, USA, TEL:732-839-4 New York/Newark Area, Newark, New Jersey Arrival Port |
MNBU4224804 [1] | 156 pcs TOTAL 156 HDPE DRUMS ( PACK ED IN 26 PALLETS ) ROSUVASTAT IN CALCIUM NDC NO: A 65862-3 04-37, ANDA #79-170 & THERAPE UTIC USE : CVS H.S CODE: 293 29990,29329900 INVOICE NO: U1 1/20-21/402, DT: 09/05/2020 | 2020-06-17 |
2020060316417 | AUROBINDO PHARMA LTD.,
CORP OFFICE : THE WATER MARK BUILDI Departure Port Salalah,Oman AGILITY LOGISTICS CORP HEIDI MONAHAN-GREY, IMPORT SUPERVIS |
AUROLIFE PHARMA LLC, 301-6 WHEELI DAYTON, NJ08810, USA, New York/Newark Area, Newark, New Jersey Arrival Port |
MNBU3900904 [1] | 147 pcs TOTAL 147 HDPE DRUMS OLANZA PINE USP FDA INFORMATION : ND C#65862-546-37, THERAPEUTIC U SE : ANTI-PSYCHOTIC ROSUVAST ATIN CALCIUM FDA INFORMATION: NDC NO : A 65862-304-37, AND A #79-170 & THERAPEUTIC USE : | 2020-06-02 |
2020060316404 | AUROBINDO PHARMA LTD.,
CORP OFFICE : THE WATER MARK BUILDI Departure Port Nhava Sheva,India AGILITY LOGISTICS CORP HEIDI MONAHAN-GREY, IMPORT SUPERVIS |
AUROLIFE PHARMA LLC, 301-6 WHEELI DAYTON, NJ08810, USA, New York/Newark Area, Newark, New Jersey Arrival Port |
MNBU0526278 [1] | 256 pcs TOTAL 256 HDPE DRUMS LEVETI RACETAM USP NDC#65862-261-3 7, THERAPEUTIC USE : ANTI-CO NVULSANT H.S CODE: 29242990 INVOICE NO: U11/20-21/175 DT. 19-APR-20 BUYER'S ORDER NO : 19202202748 DTD 03-JAN-2020 | 2020-06-02 |